QuidelOrtho Corp (QDEL)
38.35
+0.09
(+0.24%)
USD |
NASDAQ |
Apr 19, 11:45
QuidelOrtho Cash from Financing (TTM): -265.80M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -265.80M |
September 30, 2023 | -239.70M |
June 30, 2023 | -317.00M |
March 31, 2023 | 195.80M |
December 31, 2022 | 252.00M |
September 30, 2022 | 282.80M |
June 30, 2022 | 410.60M |
March 31, 2022 | -146.85M |
December 31, 2021 | -173.10M |
September 30, 2021 | -172.26M |
June 30, 2021 | -217.26M |
March 31, 2021 | -160.63M |
December 31, 2020 | -130.28M |
September 30, 2020 | -145.72M |
June 30, 2020 | -108.48M |
March 31, 2020 | -82.90M |
December 31, 2019 | -98.28M |
September 30, 2019 | -112.37M |
June 30, 2019 | -103.93M |
March 31, 2019 | -146.94M |
December 31, 2018 | -244.06M |
September 30, 2018 | 42.00M |
June 30, 2018 | 49.41M |
March 31, 2018 | 156.69M |
December 31, 2017 | 270.61M |
Date | Value |
---|---|
September 30, 2017 | 17.71M |
June 30, 2017 | 10.37M |
March 31, 2017 | 8.642M |
December 31, 2016 | -16.80M |
September 30, 2016 | -23.07M |
June 30, 2016 | -40.12M |
March 31, 2016 | -52.22M |
December 31, 2015 | -29.26M |
September 30, 2015 | 141.39M |
June 30, 2015 | 156.90M |
March 31, 2015 | 169.03M |
December 31, 2014 | 168.06M |
September 30, 2014 | 0.965M |
June 30, 2014 | 1.076M |
March 31, 2014 | 1.648M |
December 31, 2013 | 1.79M |
September 30, 2013 | -10.35M |
June 30, 2013 | -10.09M |
March 31, 2013 | -11.08M |
December 31, 2012 | -37.51M |
September 30, 2012 | -25.57M |
June 30, 2012 | -26.75M |
March 31, 2012 | -26.99M |
December 31, 2011 | 28.14M |
September 30, 2011 | 27.08M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-317.00M
Minimum
Jun 2023
410.60M
Maximum
Jun 2022
-70.18M
Average
-130.28M
Median
Dec 2020
Cash from Financing (TTM) Benchmarks
Abbott Laboratories | -7.091B |
Becton Dickinson & Co | -2.286B |
Boston Scientific Corp | 5.00M |
Tenon Medical Inc | 6.302M |
Perspective Therapeutics Inc | 0.785M |